EUDA Health Holdings Limited (EUDA)
(Delayed Data from NSDQ)
$2.23 USD
+0.17 (8.25%)
Updated Oct 3, 2025 03:59 PM ET
After-Market: $2.22 -0.01 (-0.45%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EUDA 2.23 +0.17(8.25%)
Will EUDA be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for EUDA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for EUDA
EUDA Crossed Above 50 Day Moving Average on October 3
Is EUDA heading for a slide? 50 Day Moving Average Resistance shows up after rising 1.51%
EUDA Health Holdings Amends Convertible Note Agreement
Is EUDA gaining bullish strength? Stochastic Reached Overbought shows up after surging 14.7%
NR7 appears for EUDA after 2.97% move